Yuki Ichikawa

403 total citations
16 papers, 287 citations indexed

About

Yuki Ichikawa is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yuki Ichikawa has authored 16 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Yuki Ichikawa's work include Liver Disease Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (3 papers) and Hepatitis B Virus Studies (3 papers). Yuki Ichikawa is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Extracellular vesicles in disease (3 papers) and Hepatitis B Virus Studies (3 papers). Yuki Ichikawa collaborates with scholars based in Japan, United States and Slovakia. Yuki Ichikawa's co-authors include Takeji Umemura, Satoru Joshita, Akihiro Matsumoto, Michiharu Komatsu, Eiji Tanaka, Tomoo Yamazaki, Soichiro Shibata, Naoyuki Fujimori, Yoko Usami and Ayumi Sugiura and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Analytical Chemistry.

In The Last Decade

Yuki Ichikawa

13 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Ichikawa Japan 9 181 150 96 45 24 16 287
Changyu Zhou China 10 119 0.7× 82 0.5× 103 1.1× 30 0.7× 8 0.3× 22 359
Karolina Szafranska Norway 11 108 0.6× 129 0.9× 80 0.8× 23 0.5× 72 3.0× 21 328
Shun Kaneko Japan 14 522 2.9× 524 3.5× 62 0.6× 50 1.1× 12 0.5× 55 695
Mitsuko Hara Japan 8 105 0.6× 108 0.7× 103 1.1× 28 0.6× 21 0.9× 10 250
Nicole Loo United States 10 472 2.6× 259 1.7× 141 1.5× 67 1.5× 61 2.5× 25 633
Shodai Togo Japan 5 33 0.2× 117 0.8× 109 1.1× 59 1.3× 18 0.8× 7 291
Bruno Caspani Italy 7 122 0.7× 242 1.6× 16 0.2× 88 2.0× 13 0.5× 9 351
Fuquan Liu China 8 128 0.7× 120 0.8× 81 0.8× 70 1.6× 18 0.8× 25 241
Ammu Susheela United States 6 64 0.4× 76 0.5× 67 0.7× 34 0.8× 4 0.2× 19 240
Makoto Ocho Japan 6 253 1.4× 239 1.6× 100 1.0× 27 0.6× 17 0.7× 7 350

Countries citing papers authored by Yuki Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Yuki Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ichikawa more than expected).

Fields of papers citing papers by Yuki Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ichikawa. The network helps show where Yuki Ichikawa may publish in the future.

Co-authorship network of co-authors of Yuki Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Ichikawa. A scholar is included among the top collaborators of Yuki Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Ichikawa. Yuki Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Hirasawa, Yosuke, Atsushi Satomura, Mitsuyoshi Utsugi, et al.. (2025). Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers. 17(16). 2640–2640.
3.
Syková, Eva, Ivan Voříšek, Zenon Starčuk, et al.. (2025). Disruption of Extracellular Matrix and Perineuronal Nets Modulates Extracellular Space Volume and Geometry. Journal of Neuroscience. 45(8). e0517242024–e0517242024. 3 indexed citations
4.
Kondo, Shunsuke, Tatsuya Yoshida, Hiroki Yamaguchi, et al.. (2025). Analysis of serum and urine miRNAs as biomarkers of cancer cachexia in pancreatic cancer.. Journal of Clinical Oncology. 43(4_suppl). 773–773.
5.
Matsuda, Satoru, Hiroki Yamaguchi, Yuki Ichikawa, et al.. (2024). Identifying the Trends of Urinary microRNAs within Extracellular Vesicles for Esophageal Cancer. Cancers. 16(9). 1698–1698. 1 indexed citations
6.
Yasui, Takao, Atsushi Natsume, Takeshi Yanagida, et al.. (2024). Early Cancer Detection via Multi-microRNA Profiling of Urinary Exosomes Captured by Nanowires. Analytical Chemistry. 96(43). 17145–17153. 7 indexed citations
7.
Ichikawa, Yuki, et al.. (2023). Suppression of threshold voltage shift due to positive bias stress in GaN planar MOSFETs by post-deposition annealing. Japanese Journal of Applied Physics. 63(2). 02SP31–02SP31. 3 indexed citations
8.
Komarov, Denis A., Yuki Ichikawa, Kumiko Yamamoto, et al.. (2018). In Vivo Extracellular pH Mapping of Tumors Using Electron Paramagnetic Resonance. Analytical Chemistry. 90(23). 13938–13945. 30 indexed citations
9.
Joshita, Satoru, Yuki Ichikawa, Takeji Umemura, et al.. (2017). Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology Research. 48(4). 275–285. 31 indexed citations
10.
Yamazaki, Tomoo, Satoru Joshita, Takeji Umemura, et al.. (2017). Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C. Scientific Reports. 7(1). 46705–46705. 51 indexed citations
11.
Tanaka, Naoki, Naoyuki Fujimori, Michiharu Komatsu, et al.. (2017). Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World Journal of Gastroenterology. 23(4). 712–712. 43 indexed citations
12.
Shibata, Soichiro, Satoru Joshita, Takeji Umemura, et al.. (2016). Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. SpringerPlus. 5(1). 998–998. 12 indexed citations
13.
Umemura, Takeji, Satoru Joshita, Tomoo Yamazaki, et al.. (2016). Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis. Liver International. 37(6). 897–905. 18 indexed citations
15.
Shibata, Soichiro, Takeji Umemura, Tomoo Yamazaki, et al.. (2015). Liver stiffness‐spleen size‐to‐platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C. Hepatology Research. 46(9). 884–889. 13 indexed citations
16.
Joshita, Satoru, Takeji Umemura, Yoshihiko Katsuyama, et al.. (2011). Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection. Human Immunology. 73(3). 298–300. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026